The sulfonamide group as a structural alert: A distorted story?

Current Opinion in Drug Discovery and Development

Volumn 11, Issue 1, 2008, Pages 72-79

  Smith, D A ^a   Jones, R M ^a  

^a PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United Kingdom)

Author keywords

Erythema multiforme; Hydroxylamine; Stevens Johnson syndrome; Sulfonamide; Toxic epidermal necrolysis

Indexed keywords

4 AMINOBENZOIC ACID; ACETAZOLAMIDE; ACETOHEXAMIDE; ALMOTRIPTAN; ALTIZIDE; AMPRENAVIR; AMSACRINE; ANTIBIOTIC AGENT; ARGATROBAN; AVITRIPTAN; BEMETIZIDE; BENDROFLUMETHIAZIDE; BENZTHIAZIDE; BOSENTAN; BRINZOLAMIDE; BUMETANIDE; BUTIZIDE; CARBUTAMIDE; CELECOXIB; CHLOROTHIAZIDE; CHLORPROPAMIDE; CHLORTALIDONE; CINNOXICAM; DIETHYLENE GLYCOL; ENZYME INHIBITOR; SULFANILAMIDE; SULFANILAMIDE DERIVATIVE; SULFONAMIDE; TETRAHYDROPTEROIC ACID SYNTHASE INHIBITOR; UNCLASSIFIED DRUG; UNINDEXED DRUG;

BLOOD DISEASE; CARDIOVASCULAR DISEASE; DISEASE ASSOCIATION; DRUG HYPERSENSITIVITY; DRUG STRUCTURE; ERYTHEMA MULTIFORME; HISTORY OF MEDICINE; HUMAN; RASH; RESPIRATORY TRACT DISEASE; REVIEW; SKIN DISEASE; SKIN MANIFESTATION; STEVENS JOHNSON SYNDROME; TOXIC EPIDERMAL NECROLYSIS; UNITED STATES; URINARY TRACT DISEASE;

ANIMALS; ANTI-BACTERIAL AGENTS; CARBONIC ANHYDRASE INHIBITORS; CYCLOOXYGENASE 2 INHIBITORS; DRUG HYPERSENSITIVITY; HUMANS; HYPOGLYCEMIC AGENTS; STRUCTURE-ACTIVITY RELATIONSHIP; SULFONAMIDES;

EID: 37849012349     PISSN: 13676733     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (25)

1. Choquet-Kastylevsky G, Vial T, Descotes J: Allergic adverse reactions to sulfonamides. Curr Allergy Asthma Rep (2002) 2(1):16-25.
2. Spielberg SP: N-Acetyltransferases: Pharmacogenetics and clinical consequences of polymorphic drug metabolism. J Pharmacokinet Biopharm (1996) 24(5):509-519.
3. Reilly TP, Lash LH, Doll MA, Hein DW, Woster PM, Svensson CK: A role for bioactivation and covalent binding within epidermal keratinocytes in sulfonamide-induced cutaneous drug reactions. J Invest Dermatol (2000) 114(6):1164-1173.
4. Hare RL, Holcomb B, Page OC, Stephens JW: Toxicity of carbutamide: Report of a fatal case of bone marrow depression and anuria. N Engl J Med (1957) 256(2):74-76.
5. Kresbach H: On the recognition of drug exanthem caused by oral antidiabetics. Dermatol Wochenschr (1959) 140:1091-1096.
6. Bernhard H: Long-term observations on oral hypoglycemic agents in diabetes: The effect of carbutamide and tolbutamide. Diabetes (1965) 14(2):59-70.
7. Shamov IA: Case of Lyell's syndrome caused by bucarban. Klin Med (1978) 56(3):135-136.
8. Duperrat B, Noury JY, Pringuet R: Diffuse and mortal epidermal necrosis of the Lyell type. Positive Shelley test with furadoin and glucidoral. Bull Soc Fr Dermatol Syphiligr (1967) 74(4):423-424.
9. Srivastava DK, Jude KM, Banerjee AL, Haldar M, Manokaram S, Kooren J, Mallik S, Christianson DW: Structural analysis and charge discrimination in the binding of inhibitors to human carbonic anhydrases I and II. J Am Chem Soc (2007) 129(17):5528-5537.
10. Abbate F, Supuran CT, Scozzafava A, Orioli P, Stubbs MT, Klebe G: Nonaromatic sulfonamide group as ideal anchor for potent human carbonic anhydrase inhibitors: Role of hydrogen bonding networks in ligand binding and drug design. J Med Chem (2002) 45(17):3583-3587. • Reports the X-ray crystal structures of compounds containing a sulfamide or a sulfamic acid group bound to adducts of human CA isozyme II.
11. Gerhards LJ, van Arnhem AC, Holman ND, Nossent GD: Fatal anaphylactic reaction after oral acetazolamide (diamox) for glaucoma. Ned Tijdschr Geneeskd (2000) 144(25):1228-1230.
12. Gallerani M, Manzoli N, Fellin R, Simonato M, Orzincolo C: Anaphylactic shock and acute pulmonary edema after a single oral dose of acetazolamide. Am J Emerg Med (2002) 20(4):371-372.
13. Lee AG, Anderson R, Kardon RH, Wall M: Presumed "sulfa allergy" in patients with intracranial hypertension treated with acetazolamide or furosemide: Cross-reactivity, myth or reality? Am J Ophthalmol (2004) 138(1):114-118. • Describes a study of patients presenting with intracranial hypertension or a self-reported sulfa allergy following treatment with acetazolamide or furosemide, and discusses the likely outcome of such cases.
14. Patel SM, Johnson S, Belknap SM, Chan J, Sha BE, Bennett C: Serious adverse cutaneous and hepatic toxicities associated with nevirapine use by non-HIV-infected individuals. J Acquir Immune Defic Syndr (2004) 35(2):120-125.
15. Roujeau JC, Kelly JP, Naldi L, Rzany B, Stern RS, Anderson T, Auquier A, Bastuji-Garin S, Correia O, Locati F et al: Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. N Engl J Med (1995) 333(24):1600-1607.
16. La Grenade L, Lee L, Weaver J, Bonnel R, Karwoski C, Governale L, Brinker A: Comparison of reporting of Stevens-Johnson syndrome and toxic epidermal necrolysis in association with selective COX-2 inhibitors. Drug Saf (2005) 28(10):917-924.
17. Schmid J, Busch U, Heinzel G, Bozler G, Kaschke S, Kummer M: Pharmacokinetics and metabolic pattern after intravenous infusion and oral administration to healthy subjects. Drug Metab Dispos (1995) 23(11):1206-1213.
18. Patterson R, Bello AE, Lefkowith J: Immunologic tolerability profile of celecoxib. Clin Ther (1999) 21(12):2065-2079.
19. Brackett CC: Sulfonamide allergy and cross-reactivity. Curr Allergy Asthma Rep (2007) 7(1):41-48. • Provides a review describing the mechanisms for the effects of sulfonamide antibiotics and non-antibiotic sulfonamide-containing drugs on cellular or humoral immunity.
20. Shear NH, Spielberg SP, Grant DM, Tang BK, Kalow W: Differences in metabolism of sulfonamides predisposing to idiosyncratic toxicity. Ann Intern Med (1986) 105(2):179-184.
21. Rieder MJ, Uetrecht J, Shear NH, Cannon M, Miller M, Spielberg SP: Diagnosis of sulfonamide hypersensitivity reactions by in vitro "rechallenge" with hydroxylamine metabolites. Ann Intern Med (1989) 110(4):286-289. • Describes a study to establish whether there were detectable differences in the lymphocytes of control subjects, patients experiencing sulfonamide hypersensitivity reactions and patients with non-hypersensitivity reactions as a result of treatment with sulfonamide agents.
22. Knowles S, Shapiro L, Shear NH: Should celecoxib be contra-indicated in patients who are allergic to sulfonamides? Revisiting the meaning of 'sulfa' allergy. Drug Saf (2001) 24(4):239-247. • Describes an investigation into the accuracy of the contraindication of celecoxib for patients with demonstrated allergic reactions to sulfonamides.
23. Toler SM, Rodriguez I: Not all sulfa drugs are created equal. Ann Pharmacother (2004) 38(12):2166-2167.
24. Wiholm B-E: Identification of sulfonamide-like adverse drug reactions to celecoxib in the World Health Organization database. Curr Med Res Opin (2001) 17(3):210-216.
25. Ziemer M, Wiesend CL, Vetter R, Weiss J, Blaschke S, Norgauer J, Mockenhaupt M: Cutaneous adverse reactions to valdecoxib distinct from Stevens-Johnson syndrome and toxic epidermal necrolysis. Arch Dermatol (2007) 143(6):711-716. • Describes a study designed to assess the types of severe skin reactions caused by treatment with valdecoxib.